Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA
- PMID: 7189592
- DOI: 10.1016/0091-3057(80)90353-6
Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA
Abstract
Partial, unilateral lesions of the nigro-striatal tract were produced in rats by injecting various quantities of 6-hydroxydopamine into the substantia nigra. The extent of each animal's lesion was estimated by comparing tyrosine hydroxylase activities in its lesioned and control striata. L-DOPA and apomorphine induced contralateral (i.e., away from the lesion) circling behavior only in rats in which more than 90% of the nigro-striatal system had been destroyed. In contrast, d-amphetamine caused turning in the ipsilateral direction when as few as 50% of the nigro-striatal neurons had been destroyed.
Similar articles
-
Proceedings: Differences in circling responses following electrolytic and 6-hydroxydopamine lesions of the nigro-striatal pathway.Br J Pharmacol. 1975 Oct;55(2):289P-290P. Br J Pharmacol. 1975. PMID: 1238135 Free PMC article. No abstract available.
-
The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.J Pharmacol Exp Ther. 1980 Sep;214(3):651-6. J Pharmacol Exp Ther. 1980. PMID: 6772760
-
Ascorbate blocks amphetamine-induced turning behavior in rats with unilateral nigro-striatal lesions.Brain Res Bull. 1979 Jan-Feb;4(1):43-8. doi: 10.1016/0361-9230(79)90056-x. Brain Res Bull. 1979. PMID: 572739
-
Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.Pharmacol Ther B. 1976;2(1):41-7. doi: 10.1016/0306-039x(76)90017-9. Pharmacol Ther B. 1976. PMID: 817332 Review. No abstract available.
-
6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome.Pharmacol Ther B. 1976;2(1):37-40. doi: 10.1016/0306-039x(76)90016-7. Pharmacol Ther B. 1976. PMID: 772721 Review. No abstract available.
Cited by
-
Locomotor effects of imidazoline I2-site-specific ligands and monoamine oxidase inhibitors in rats with a unilateral 6-hydroxydopamine lesion of the nigrostriatal pathway.Br J Pharmacol. 2004 Dec;143(8):952-9. doi: 10.1038/sj.bjp.0706019. Epub 2004 Nov 15. Br J Pharmacol. 2004. PMID: 15545290 Free PMC article.
-
Effects of pcDNA3-beta-NGF gene-modified BMSC on the rat model of Parkinson's disease.J Mol Neurosci. 2008 Jun;35(2):161-9. doi: 10.1007/s12031-007-9032-8. Epub 2008 Feb 14. J Mol Neurosci. 2008. PMID: 18273710
-
Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease.Front Neuroanat. 2017 Dec 8;11:109. doi: 10.3389/fnana.2017.00109. eCollection 2017. Front Neuroanat. 2017. PMID: 29276478 Free PMC article.
-
Deep Brain Stimulation of Hemiparkinsonian Rats with Unipolar and Bipolar Electrodes for up to 6 Weeks: Behavioral Testing of Freely Moving Animals.Parkinsons Dis. 2017;2017:5693589. doi: 10.1155/2017/5693589. Epub 2017 Jul 3. Parkinsons Dis. 2017. PMID: 28758044 Free PMC article.
-
Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.Br J Pharmacol. 1986 Jan;87(1):257-64. doi: 10.1111/j.1476-5381.1986.tb10179.x. Br J Pharmacol. 1986. PMID: 3082400 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources